510(k) Report

510(k) · Cleared

Cleared

Cellvizio 100 Series System and Cellvizio System with Confocal Miniprobes

K120208510(k) SpecialCleared Apr 20, 201287-day reviewClass II21 CFR 876.1500

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Mauna Kea Technologies · OWN Confocal Optical Imaging

Cleared on Apr 20, 2012 after an 87-day review. FDA has not posted a summary or statement for it, so its predicates are not known. 13 later devices descend from it.

Decided
Apr 20, 2012
Review
87 days
Class
Class II
Product code
OWN
Recalls
None
Predicates
0

13 later devices descend from it, 2 citing it directly.

Descendants, by year cleared 2012: 1 descendant cleared2013: 1 descendant cleared2017: 1 descendant cleared2015: 1 descendant cleared2019: 1 descendant cleared2014: 2 descendants cleared2020: 2 descendants cleared2024: 1 descendant cleared2016: 1 descendant cleared2025: 1 descendant cleared2021: 1 descendant cleared2010201520202025
  1. This deviceK120208 Cellvizio 100 Series System and Cellvizio System with Confocal…Mauna Kea Technologies · 2012
  2. Descendant · cites it directly · 11 of its ownK123676 Cellvizio 100 Series and Cellvizio Systems with Confocal MiniprobesMauna Kea Technologies · 2013
  3. Descendant · 2 generations on · 10 of its ownK132389 Cellvizio 100 Series System and Cellvizio System with Confocal…Daniel & Daniel Consulting · 2014
  4. Descendant · 3 generations on · 9 of its ownK141358 Cellvizio 100 Series with System Confocal MiniprobesMauna Kea Technologies · 2014
  5. Descendant · cites it directly · 8 of its ownK122042 Cellvizio 100 Series and Cellvizio Systems with Confocal MiniprobesMauna Kea Technologies · 2012
  6. Descendant · 4 generations on · 7 of its ownK160416 CystoFlex UHD R-C, CelioFlex UHD 5-C, Cellvizio 100 Series (800)…Mauna Kea Technologies · 2016

Showing 5 of 13 descendants. See all descendants

Descendants cleared per year

2012: 12013: 12014: 22015: 12016: 12017: 12019: 12020: 22021: 12024: 12025: 1
2012high 2 (2014) · low 0 (2018)2026

Most influential descendants

Showing 5 of 13 · See all
  • K123676Cellvizio 100 Series and Cellvizio Systems with Confocal MiniprobesMauna Kea Technologies · 2013 · cites it directly11descendants
  • K132389Cellvizio 100 Series System and Cellvizio System with Confocal Miniprobes; Uroflex B and…Daniel & Daniel Consulting · 2014 · 2 generations on10descendants
  • K141358Cellvizio 100 Series with System Confocal MiniprobesMauna Kea Technologies · 2014 · 3 generations on9descendants
  • K122042Cellvizio 100 Series and Cellvizio Systems with Confocal MiniprobesMauna Kea Technologies · 2012 · cites it directly8descendants
  • K160416CystoFlex UHD R-C, CelioFlex UHD 5-C, Cellvizio 100 Series (800) with Confocal MiniprobesMauna Kea Technologies · 2016 · 4 generations on7descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K120208Cellvizio 100 Series System and Cellvizio System with Confocal MiniprobesMauna Kea Technologies2012—
+1K123676Cellvizio 100 Series and Cellvizio Systems with Confocal MiniprobesMauna Kea Technologies2013—
+2K132389Cellvizio 100 Series System and Cellvizio System with Confocal Miniprobes…Daniel & Daniel Consulting2014—
+3K141358Cellvizio 100 Series with System Confocal MiniprobesMauna Kea Technologies2014—
+1K122042Cellvizio 100 Series and Cellvizio Systems with Confocal MiniprobesMauna Kea Technologies2012—
+4K160416CystoFlex UHD R-C, CelioFlex UHD 5-C, Cellvizio 100 Series (800) with Confocal…Mauna Kea Technologies2016—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201210
201310
201420
201510
201610
201710
201910
202020
202110
202410
202510
FIG. 1 — Lineage of K120208, 2012–2025Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in OWN? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new OWN device

  1. #1 K231854 1788 4K Camera System with Advanced Imaging…score 24.9 · 24 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against?

FDA has not posted a summary or statement for it, so its predicates are not known.

What descends from it? (13)

See all 13

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K123676Cellvizio 100 Series and Cellvizio Systems with Confocal MiniprobesMauna Kea Technologies201311
K122042Cellvizio 100 Series and Cellvizio Systems with Confocal MiniprobesMauna Kea Technologies20128

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K123676 (Mauna Kea Technologies, 2013) has gone furthest, with 11 descendants of its own.

How does its category compare?

All OWN devices

OWN Confocal Optical Imaging: FDA decisions, review times, recalls and adverse event reports over 20 years. 2012, this device’s year, is highlighted.

FDA decisions per year · OWN

3in 2025

2011: 12012: 32013: 22014: 52015: 52016: 22017: 52018: 12019: 72020: 72021: 42022: 42023: 62024: 12025: 32026 (partial year): 7
2007high 7 (2019) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · OWN

196in 2025

2012: 87 days median2014: 208 days median2015: 163 days median2017: 87 days median2019: 81 days median2020: 81 days median2021: 104 days median2022: 41 days median2023: 69 days median2025: 196 days median2026 (partial year): 63 days median
2007high 208 (2014) · low 41 (2022)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · OWN

1in 2024

2022: 32024: 1
2007high 3 (2022) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · OWN

197in 2025

2015: 12016: 42017: 122018: 112019: 592020: 1052021: 3122022: 3462023: 1642024: 1652025: 197
2007high 346 (2022) · low 0 (2007)2025

MAUDE reports naming product code OWN, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20111—00
201238700
20132—00
2014520800
2015516301
20162—04
2017587012
20181—011
2019781059
20207810105
202141040312
20224413346
20236690164
20241—1165
202531960197
20267630—
Cite this page

510(k) Report. “K120208: Cellvizio 100 Series System and Cellvizio System with Confocal Miniprobes.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K120208

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026